- Home
- RXT vs RNAC Comparison
RXT vs RNAC Comparison
Compare RXT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- RNAC
- Stock Information
- Founded
- RXT 1998
- RNAC 2007
- Country
- RXT United States
- RNAC United States
- Employees
- RXT N/A
- RNAC N/A
- Industry
- RXT EDP Services
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- RNAC Health Care
- Exchange
- RXT Nasdaq
- RNAC Nasdaq
- Market Cap
- RXT 280.1M
- RNAC 276.3M
- IPO Year
- RXT 2020
- RNAC 2016
- Fundamental
- Price
- RXT $1.26
- RNAC $10.05
- Analyst Decision
- RXT Hold
- RNAC Strong Buy
- Analyst Count
- RXT 5
- RNAC 4
- Target Price
- RXT $1.58
- RNAC $40.00
- AVG Volume (30 Days)
- RXT 764.7K
- RNAC 48.4K
- Earning Date
- RXT 08-07-2025
- RNAC 08-07-2025
- Dividend Yield
- RXT N/A
- RNAC N/A
- EPS Growth
- RXT N/A
- RNAC N/A
- EPS
- RXT N/A
- RNAC N/A
- Revenue
- RXT $2,693,100,000.00
- RNAC $1,026,000.00
- Revenue This Year
- RXT N/A
- RNAC N/A
- Revenue Next Year
- RXT $1.48
- RNAC N/A
- P/E Ratio
- RXT N/A
- RNAC N/A
- Revenue Growth
- RXT N/A
- RNAC N/A
- 52 Week Low
- RXT $1.00
- RNAC $8.46
- 52 Week High
- RXT $3.41
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- RXT 52.70
- RNAC 34.71
- Support Level
- RXT $1.14
- RNAC $10.50
- Resistance Level
- RXT $1.31
- RNAC $11.80
- Average True Range (ATR)
- RXT 0.08
- RNAC 0.56
- MACD
- RXT 0.01
- RNAC -0.11
- Stochastic Oscillator
- RXT 79.55
- RNAC 0.45
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.